Youngevity International, Inc. Provides Financial Reporting and Business Update
SAN DIEGO, March 22, 2021 /PRNewswire/ -- Youngevity International, Inc. (OTCMKTS: YGYI), a multi-channel lifestyle company operating in three distinct...
SAN DIEGO, March 22, 2021 /PRNewswire/ -- Youngevity International, Inc. (OTCMKTS: YGYI), a multi-channel lifestyle company operating in three distinct...
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins...
Luminar Systems, Inc. (NASDAQ: LAZR), the international chief in automotive lidar hardware and software package engineering, is saying now business...
TipRanks3 Huge Dividend Shares Yielding at Minimum 8% Analysts Say ‘Buy’Do you like roller coasters? In accordance to Deutsche Lender,...
(Updates with company revising complete situations to 27 from 25, 4 finished, not two, further remark from agency on FSD...
Conference Call and Webcast Today at 8:30 a.m. ETCOVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim...
TipRanks3 Huge Dividend Shares Yielding at Least 8% Analysts Say ‘Buy’Do you like roller coasters? According to Deutsche Bank, we’re...
AICPA Academic Source Hub Gives School Instruments to Deal with Gaps in Their Rising Concerns and Engineering-Related CurriculumThere are key...
Marseille, March 18, 2021 (GLOBE NEWSWIRE) --Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development...
Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programsEnds 2020 with cash exceeding $33 million and...
RESTON, Va., March 17, 2021 (Globe NEWSWIRE) -- Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel know-how business, today introduced...
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical...
Clinical data and program update planned for lead program zenocutuzumab (“Zeno”) in 2Q 2021Clinical update planned for MCLA-145 in 2H...
TipRanksWells Fargo: 2 Persuasive Stocks With More than 70% Upside PossibleThe analysts at Wells Fargo have been scrutinizing the market...
– FOTIVDA® (tivozanib) Approved for Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma Following Two or More Prior...
Shares of Southwest Airways jumped just about 1.8% on Monday to near at $62.10 immediately after the world’s premier lower-price...
MURFREESBORO, TN / ACCESSWIRE / March 15, 2021 / National Health Investors, Inc. (NYSE:NHI) today provided a business update regarding...
- First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021-Translational preclinical data for sAAVy platform...